Expertise in
1
conditions

Changhao L. Xie

No.2600, Donghai Avenue, 
Bengbu, CN 
Expertise in
1
conditions
No.2600, Donghai Avenue, 
Bengbu, CN 

Overview

Changhao Xie practices practicing medicine in Bengbu, China.

Xie is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Arthritis, Ankylosing Spondylitis, and Lupus Nephritis.

They are actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 1 clinical trial.

Locations

No.2600, Donghai Avenue, Bengbu, 233000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3

36 Total Publications

Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study.
Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study.
Journal: Journal of autoimmunity
Published: February 12, 2026

Frequently Asked Questions about Changhao L. Xie

Is Changhao L. Xie a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Changhao L. Xie is classified as an Advanced expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Changhao L. Xie participate in research or clinical trials?

Yes. Changhao L. Xie has published 36 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Changhao L. Xie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xie's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile